CHIR-21208

Overview

CHIR-21208 is a highly selective glycogen synthase kinase-3 ( GSK-3 ) inhibitor. CHIR-21208 is promising for research of neurodegenerative disorders like Alzheimer's disease and type 2 diabetes.

Application

Products | Products > Disease Areas > Type 2 Diabetes | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Disease Areas > Neurodegenerative Disease | Products > Disease Areas > Glucose Metabolism | Products > Disease Areas > Alzheimer's Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Neurological Disease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > GSK-3

Product Information

• Catalog No.: HY-117198
• CAS No.: 206275-65-2
• Molecular Formula: C19H20F3N7O3
• Molecular Weight: 451.41
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source